Septic arthritis due to Salmonella enteritidis associated with infliximab use.
A unique case of septic arthritis caused by Salmonella enteritidis in a patient receiving infliximab for rheumatoid arthritis is presented. Antimicrobial chemotherapy with surgical intervention was necessary for eradication of the infection. Physicians should be aware of rare manifestations of Salmonella infections associated with infliximab use, especially in endemic areas.
Katsarolis
Ioannis
I
Fourth Department of Internal Medicine, Attikon University General Hospital, Athens University Medical School, Athens, Greece. ikatsarolis@yahoo.com
Tsiodras
Sotirios
S
Panagopoulos
Periklis
P
Giannitsioti
Efthymia
E
Skarantavos
Grigorios
G
Ioannidis
Theologos
T
Giamarellou
Helen
H
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001170:Arthritis, Infectious / Q000139:chemically induced* / Q000382:microbiology; D005260:Female; D006801:Humans; D000069285:Infliximab; D008875:Middle Aged; D012480:Salmonella Infections / Q000139:chemically induced* / Q000382:microbiology; D012477:Salmonella enteritidis / Q000302:isolation & purification*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab